Lichen China Limited (NASDAQ:LICN – Get Free Report) was the target of a large decrease in short interest in October. As of October 31st, there was short interest totalling 91,000 shares, a decrease of 16.9% from the October 15th total of 109,500 shares. Based on an average daily volume of 352,300 shares, the short-interest ratio is presently 0.3 days. Approximately 0.4% of the company’s stock are short sold.
Lichen China Trading Up 4.4 %
NASDAQ:LICN opened at $1.88 on Friday. Lichen China has a 52 week low of $0.50 and a 52 week high of $2.44. The firm has a 50-day moving average price of $1.89 and a two-hundred day moving average price of $1.76.
Institutional Trading of Lichen China
A hedge fund recently bought a new stake in Lichen China stock. XTX Topco Ltd bought a new position in shares of Lichen China Limited (NASDAQ:LICN – Free Report) during the second quarter, according to its most recent filing with the SEC. The fund bought 37,315 shares of the company’s stock, valued at approximately $54,000. XTX Topco Ltd owned 0.14% of Lichen China at the end of the most recent reporting period.
Lichen China Company Profile
Lichen China Limited, together with its subsidiaries, operates as an investment holding company, provides financial and taxation, education support, and software and maintenance services in the People's Republic of China and internationally. The company offers financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation services; and education support services, including marketing, operational, and technical support, as well as sells teaching and learning materials.
Featured Articles
- Five stocks we like better than Lichen China
- How to Use the MarketBeat Excel Dividend Calculator
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- The Significance of Brokerage Rankings in Stock Selection
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Lichen China Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lichen China and related companies with MarketBeat.com's FREE daily email newsletter.